Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sword Diagnostics logo — Pioneering the future of life sciences, making biomarker dis...

Sword Diagnostics

Pioneering the future of life sciences, making biomarker discovery and analysis more accessible and effective.

Founded 2004 11-50 employees Venture round Total: $5.45M Biotechnology, Health Care

General Information

Company Name Sword Diagnostics
Founded Year 2004
Employees 11-50
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Sword Diagnostics. To contact Sword Diagnostics, visit sworddiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sword Diagnostics compare?

A PDF of Sword Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sword Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sword Diagnostics

Sword Diagnostics, founded in 2004, is a biotechnology and healthcare company that is revolutionizing the life sciences industry. The company's slogan, "Pioneering the future of life sciences, making biomarker discovery and analysis more accessible and effective," reflects its commitment to advancing biomarker research and diagnostics. Sword Diagnostics addresses the evolving needs of the research, pharmaceutical, and clinical sectors by focusing on simplifying the understanding of newly identified biomarkers and enhancing the effectiveness of existing diagnostic assays. Despite the significant discovery of numerous biomarkers associated with healthy and disease-related biological processes, current life science tools have limitations in measuring, quantifying, and determining the significance of these biomarkers. Sword Diagnostics' technology aims to bridge this gap by developing innovative solutions that enable more accessible and effective biomarker discovery and analysis. In November 2017, Sword Diagnostics secured a Venture Round investment from Avant Global, demonstrating the company's attractiveness to investors who recognize the potential impact of its groundbreaking approach to life sciences. This investment serves as a testament to Sword Diagnostics' potential for growth and innovation in the biotechnology and healthcare industries, positioning it as a compelling opportunity for venture capital consideration.

Business keywords: Biomarker discovery, Life sciences, Diagnostic assays, Clinical research, Pharmaceutical industry, Biological markers, Research innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Avant Global
Avant Global
11 Nov 2017
Debt Financing $150.00K -
13 May 2015
Debt Financing $1.27M -
28 Dec 2012
Angel Round Undisclosed 1
Keiretsu Forum Northwest
Keiretsu Forum Northwest
16 Nov 2012
Debt Financing $435.83K -
14 Oct 2009
Series B $1.49M 1
NJTC Venture Fund
05 Mar 2007
Series A $1.60M 2
Jumpstart New Jersey Angel Network
Jumpstart New Jersey Angel Network, NJTC Venture Fund
13 Oct 2006
Venture Round $500.00K 2
Jumpstart New Jersey Angel Network
Jumpstart New Jersey Angel Network, NJTC Venture Fund
01 Apr 2005

Sword Diagnostics Alternatives & Competitors

View All Alternatives
Sword Diagnostics vs
Intrinsic LifeSciences LLC
Intrinsic LifeSciences LLC United States

First in Hepcidin and Erythroferrone

Grant
7 employees
Biotechnology, Health Care
Sword Diagnostics vs
1200 Pharma
1200 Pharma United States

We leverage our breakthrough chemistry, cutting edge computation & data-rich models to accelerate dr...

Venture round
32 employees
Biotechnology, Health Care
Sword Diagnostics vs
iLOF
iLOF United Kingdom

Using AI and Photonics to enable a new era of personalized, precision medicine.

Venture round
40 employees
AI, Biotechnology
View all alternatives

FAQ About Sword Diagnostics

Pioneering the future of life sciences, making biomarker discovery and analysis more accessible and effective.
Sword Diagnostics was founded in 2004.
Sword Diagnostics operates in Biotechnology and Health Care. Its work centres on Biomarker discovery, Life sciences, Diagnostic assays and Clinical research.
Sword Diagnostics has approximately 11-50 employees.
Sword Diagnostics has completed 8 funding rounds, raising a total of $5.45M. The latest funding stage is Venture round.
Top alternatives and competitors to Sword Diagnostics include Intrinsic LifeSciences LLC, 1200 Pharma, iLOF, Bio-Rad Laboratories, Metabolon, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sword Diagnostics and Intrinsic LifeSciences LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sword Diagnostics, https://bouncewatch.com/company/sword-diagnostics, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes